Ilyashev & Partners has successfully represented Lifelong Meditech Private Limited, an Indian manufacturer of sterile hypodermic single-use syringes, in the anti-dumping investigation on imports into Ukraine of syringes originating from the Republic of India, the Republic of Turkey, and the People’s Republic of China.
The decision to initiate an anti-dumping investigation was made by the Interdepartmental Commission on International Trade on October 25, 2017 following complaints lodged by Hemoplast PJSC and Tyumen-Mediko-Smila Private JSC.
Ilyashev & Partners reports that on April 17, 2019 the Commission declared that, in taking account the interests of both the Indian producer and Ukrainian consumers, it was abstaining from applying measures to the products of Lifelong Meditech Private Limited. Ilyashev & Partners Partner Olena Omelchenko, who led the firm's team on the matter, described the decision as “an extremely rare result for an anti-dumping investigation.”
Lifelong Meditech Private Limited was founded in 2005 and is part of the diversified Lifelong group, which produces sterile hypodermic single-use syringes, sterile hypodermic single-use needles, and infusion sets. The company markets its products under the Safeway and Lifelong brands.
